172 related articles for article (PubMed ID: 9916949)
1. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings.
Rubin SC; Randall TC; Armstrong KA; Chi DS; Hoskins WJ
Obstet Gynecol; 1999 Jan; 93(1):21-4. PubMed ID: 9916949
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.
Rubin SC; Hoskins WJ; Saigo PE; Chapman D; Hakes TB; Markman M; Reichman B; Almadrones L; Lewis JL
Gynecol Oncol; 1991 Aug; 42(2):137-41. PubMed ID: 1894172
[TBL] [Abstract][Full Text] [Related]
3. Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.
Rubin SC; Hoskins WJ; Hakes TB; Markman M; Cain JM; Lewis JL
Am J Obstet Gynecol; 1988 Nov; 159(5):1094-8. PubMed ID: 3189442
[TBL] [Abstract][Full Text] [Related]
4. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy.
Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F
Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
6. Use of second-look laparotomy in the management of patients with ovarian epithelial malignancies.
Podczaski ES; Stevens CW; Manetta A; Whitney CW; Larson JE; Mortel R
Gynecol Oncol; 1987 Oct; 28(2):205-14. PubMed ID: 3666578
[TBL] [Abstract][Full Text] [Related]
7. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
8. A review of second-look laparotomy for ovarian cancer.
Cain JM; Saigo PE; Pierce VK; Clark DG; Jones WB; Smith DH; Hakes TB; Ochoa M; Lewis JL
Gynecol Oncol; 1986 Jan; 23(1):14-25. PubMed ID: 3943748
[TBL] [Abstract][Full Text] [Related]
9. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration.
Lippman SM; Alberts DS; Slymen DJ; Weiner S; Aristizabal SA; Luditch A; Davis JR; Surwit EA
Cancer; 1988 Jun; 61(12):2571-7. PubMed ID: 3365677
[TBL] [Abstract][Full Text] [Related]
10. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
11. Microscopic disease at second-look laparotomy in advanced ovarian cancer.
Copeland LJ; Gershenson DM; Wharton JT; Atkinson EN; Sneige N; Edwards CL; Rutledge FN
Cancer; 1985 Jan; 55(2):472-8. PubMed ID: 3965102
[TBL] [Abstract][Full Text] [Related]
12. [Follow-up of 70 patients with advanced ovarian cancer after negative second-look laparotomy].
Kojs Z; Glinski B; Pudelek J; Urbanski K; Karolewski K; Mitus J; Reinfuss M
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1):16-22. PubMed ID: 16446607
[TBL] [Abstract][Full Text] [Related]
13. [Patients with advanced ovarian cancer after negative second-look laparoscopy--follow up study].
Pudełek J; Kojs Z; Urbański K; Mituś J; Reinfuss M; Klimek M
Ginekol Pol; 2004 Feb; 75(2):85-90. PubMed ID: 15108578
[TBL] [Abstract][Full Text] [Related]
14. Secondary cytoreductive surgery - viable treatment option in the management of platinum-sensitive recurrent ovarian cancer.
Felsinger M; Minar L; Weinberger V; Rovny I; Zlamal F; Bienertova-Vasku J
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():154-160. PubMed ID: 29957400
[TBL] [Abstract][Full Text] [Related]
15. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
Obermair A; Sevelda P
Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
[TBL] [Abstract][Full Text] [Related]
16. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
17. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
18. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
Colozza M; Mosconi AM; Gori S; Belsanti V; Basurto C; De Angelis V; Giansanti M; Tonato M
Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342
[TBL] [Abstract][Full Text] [Related]
19. A formula for predicting the risk of a positive second-look laparotomy in epithelial ovarian cancer: implications for a randomized trial.
Morgan MA; Noumoff JS; King S; Mikuta JJ
Obstet Gynecol; 1992 Dec; 80(6):944-8. PubMed ID: 1333064
[TBL] [Abstract][Full Text] [Related]
20. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
Rubin SC; Jones WB; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
Obstet Gynecol; 1993 Jul; 82(1):139-42. PubMed ID: 8515914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]